BioAge Labs (BIOA) Change in Cash (2023 - 2026)

BioAge Labs has disclosed Change in Cash across 4 years of filings, most recently posting -$167.8 million for Q2 2026.

• In Q2 2026, Change in Cash fell 351.64% year-over-year to -$167.8 million; the TTM figure through Jun 2026 stood at -$146.4 million (down 338.98% YoY), while the FY2025 annual figure was -$165.5 million, down 150.23% from the prior year.
• Change in Cash came in at -$167.8 million for Q2 2026 at BioAge Labs, down from $52.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $175.4 million in Q3 2024 to a low of -$167.8 million in Q2 2026.
• Average Change in Cash over 4 years is $3.6 million, with a median of -$9.6 million recorded in 2023.
• Year-over-year, Change in Cash jumped 307.53% in 2024 and plunged 351.64% in 2026.
• Over 4 years, Change in Cash stood at -$9.6 million in 2023, then jumped by 307.53% to $19.9 million in 2024, then plunged by 234.26% to -$26.7 million in 2025, then tumbled by 528.87% to -$167.8 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$167.8 million in Q2 2026, $52.9 million in Q1 2026, and -$26.7 million in Q4 2025.